bca101,pembrolizumab,cetuximab
bicara,merck,eli lilly
['bca101', 'bca101 ', 'pembro']
very promising activity observed with bca101 + pembro in p16 negative cps 1-19% 1st line r/m hnscc. exceptional presentation by at #asco23 
Clinician scientist at @vallhebron Phase 1 and Cancer Genomics Group @VHIO. Former med onc fellow at @pmcancercentre, Phase1/Head and Neck, biomarkers.